Demonstrates C−H activation in fluoroalkylated benzhydrylamines, indicating potential for drug discovery.
Abstract Fluoroalkyl groups hinder C−H activation due to steric and electronic effects. This study develops N-based directing groups that enable Cp*Rh(III)-catalyzed C−H activation/annulation of fluoroalkylated benzhydrylamines with alkynes, giving fluoroalkylated dihydroisoquinolines—promising scaffolds for drug discovery.
No takes yet. Share an insight, caveat, or question.
Tadano et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: